Skip to main content
Welcome to
super saver spring
offer ends april 20
save over $140
Sale ends in
$0.99
per week for 24 weeks
Welcome to
super saver spring
$0.99
per week for 24 weeks
save over $140
// //

Veeva Systems Inc NYSE: VEEV-N

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 265.75
Day High 271.30
Open:270.95
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Veeva Systems Inc. operates as a provider of industry-specific, cloud-based software solutions for the life sciences industry. It offers enterprise applications, a multichannel platform, customer relationship management, and content management solutions. The Company provides its solutions to pharmaceutical, animal health, and biotechnology companies. Veeva Systems Inc. is headquartered in Pleasanton, California.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Parexel and Veeva Partner to Accelerate Clinical Trials
- PR Newswire - PRF - Thu Apr 15, 9:00AM CDT
PR Newswire - PRF - CMTX
Thu Apr 15, 9:00AM CDT
and , /PRNewswire/ --  and (NYSE: VEEV) today announced a strategic collaboration to accelerate clinical trials through technology and process innovation. The unique collaboration combines the best of each company's experience across thousands of studies worldwide – Parexel as a leading clinical research organization (CRO) and Veeva as the technology innovator powering trials – to improve study efficiency and get new therapies to patients faster.
Silicon Valley Tech CFO Joins SeventySix Capital
- PRWeb - Thu Apr 1, 9:24AM CDT
PRWeb - CMTX
Thu Apr 1, 9:24AM CDT
CONSHOHOCKEN, Pa., April 1, 2021
TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development
- PR Newswire - PRF - Thu Mar 25, 3:29AM CDT
PR Newswire - PRF - CMTX
Thu Mar 25, 3:29AM CDT
, /PRNewswire/ --  (NYSE: VEEV) today announced that TFS HealthScience will be the first CRO to have selected  for end-to-end study management on a single cloud platform. The European-headquartered global CRO is taking action to further modernize the study operations, adopting the entire suite to drive greater efficiency and speed in trials. TFS HealthScience will now be offering its biopharma customers industry-leading technologies to improve patient safety whilst reducing financial burden and increasing compliance.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 244.16 +10.78% increase
on 03/25/21
Period Open:260.31
Price movement based on the high, low and last over the given period.
277.47 -2.52% decrease
on 04/16/21
+10.17 (+3.91%) increase
since 03/19/21
3-Month 235.74 +14.74% increase
on 03/05/21
Period Open:278.05
Price movement based on the high, low and last over the given period.
325.54 -16.91% decrease
on 02/16/21
-7.57 (-2.72%) decrease
since 01/19/21
52-Week 170.02 +59.09% increase
on 04/21/20
Period Open:181.12
Price movement based on the high, low and last over the given period.
325.54 -16.91% decrease
on 02/16/21
+89.36 (+49.34%) increase
since 04/17/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies